Hesham Kelani

Hesham Kelani

Auto-generated profile, based on publicly available information

Hesham Kelani

Department of Anesthesiology, Wexner Medical Center, The Ohio State University, Columbus, OH 43210, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2018 in EBioMedicine
Verified
Journal Article
Open access
ADAlessandra Drusco
Alessandra Drusco
PFPaolo Fadda
Paolo Fadda
Giovanni NigitaGiovanni Nigita
Giovanni Nigita
Matteo FassanMatteo Fassan
Matteo Fassan
ABArianna Bottoni
Arianna Bottoni
CCCarlo Crocecarlo
Carlo Crocecarlo
The World Health Organization has recently introduced molecular prognostic-diagnostic biomarkers in the classification of Central Nervous System (CNS) tumors. In order to characterize subclasses of tumors that cannot find a precise location in the current classification, and, or cannot be tested because of scant material, it is important to find new molecular biomarkers in tissue and, or biological fluid samples. In this study, we identified serum microRNAs that could serve as biomarkers for the diagnosis and prognosis of patients with tumors of glial origin. We retrospectively analyzed microRNA expression in the serum extracellular vesicles of patients with tumors of glial origin. Extracellular vesicles RNA was analyzed by Nanostring. qRT-PCR confirmed 6 overexpressed microRNAs: hsa-miR-4443, hsa-miR-422a, hsa-miR-494-3p, hsa-miR-502-5p, hsa-miR-520f-3p, and hsa-miR-549a. Hsa-miR-4443 was the only microRNA that showed significant differences in most comparisons. In situ hybridization (ISH), confirmed that our signature was mostly expressed in cancer cells. Importantly, hsa-miR-549a and hsa-miR-502-5p expression predicted prognosis in patients with tumors of glial origin. Although more studies are needed, we demonstrated that serum vesicles microRNA profiles are promising diagnostic and prognostic molecular biomarkers that will find an actual application in the clinical practice of CNS tumors.

17 October 2016 in IUBMB Life
Verified
Journal Article
Closed access
PDF file
SASomia H Abd Allah
Somia H Abd Allah
SSSally Mahmoud Shalaby
Sally Mahmoud Shalaby
AEAmal S El-Shal
Amal S El-Shal
SNSameh M El Nabtety
Sameh M El Nabtety
TKTarek Khamis
Tarek Khamis
HKHesham M Kelani
Hesham M Kelani

1 October 2018 in Annals of Diagnostic Pathology
Verified
Journal Article
Closed access
HAHamdy Awad
Hamdy Awad
ABAnna Bratasz
Anna Bratasz
NGNuovo Gerard
Nuovo Gerard
RBRichard Burry
Richard Burry
XMXiaomei Meng
Xiaomei Meng
ETEsmerina Tili
Esmerina Tili

9 July 2018 in Medicines
Verified
Journal Article
Open access
PDF file
JMJean-Jacques Michaille
Jean-Jacques Michaille
VPVictoria Piurowski
Victoria Piurowski
BRBrooke Rigot
Brooke Rigot
HKHesham Kelani
Hesham Kelani
EFEmily C. Fortman
Emily C. Fortman
ETEsmerina Tili
Esmerina Tili
Resveratrol (trans-3,5,4′-trihydroxystilbene, RSV) is a non-flavonoid dietary polyphenol with antioxidant, anti-inflammatory and anti-cancer properties that is primarily found in red berries. While RSV displays many beneficial effects in vitro, its actual effects in vivo or in animal models remain passionately debated. Recent publications suggest that RSV pleiotropic effects could arise from its capability to regulate the expression and activity of microRNAs, short regulators themselves capable of regulating up to several hundreds of target genes. In particular, RSV increases microRNA miR-663 expression in different human cell lines, suggesting that at least some of its multiple beneficial properties are through the modulation of expression of this microRNA. Indeed, the expression of microRNA miR-663 is reduced in certain cancers where miR-663 is considered to act as a tumor suppressor gene, as well as in other pathologies such as cardiovascular disorders. Target of miR-663 include genes involved in tumor initiation and/or progression as well as genes involved in pathologies associated with chronic inflammation. Here, we review the direct and indirect effects of RSV on the expression of miR-663 and its target transcripts, with emphasise on TGFβ1, and their expected health benefits, and argue that elucidating the molecular effects of different classes of natural compounds on the expression of microRNAs should help to identify new therapeutic targets and design new treatments.

1 September 2018
Verified
Journal Article
Closed access
MYMonkez Yousif
Monkez Yousif
AFAhmed Elsadek Fakhr
Ahmed Elsadek Fakhr
EMEmad Abdelhamid Morad
Emad Abdelhamid Morad
HKHesham Kelani
Hesham Kelani
EHEmad Hamed
Emad Hamed
HFHesham A Farrag
Hesham A Farrag

30 January 2023 in Anesthesiology
Verified
Journal Article
Open access
PDF file
HKHesham Kelani
Hesham Kelani
KCKara Corps
Kara Corps
SMSarah Mikula
Sarah Mikula
LFLesley C. Fisher
Lesley C. Fisher
MSMahmoud T. Shalaan
Mahmoud T. Shalaan
HAHamdy Awad
Hamdy Awad
Background: A clinically relevant mouse model of thoracic endovascular aortic repair–induced ischemic spinal cord injury has been lacking since the procedure was first employed in 1991. The hypothesis was that ligation of mouse intercostal arteries would simulate thoracic endovascular aortic repair–induced ischemic spinal cord injury and behavioral deficit. The aim was to create a mouse model of thoracic endovascular aortic repair–induced spinal cord hypoperfusion by ligating five pairs of mouse intercostal vessels. Methods: Mice were divided into sham (n = 53) and ligation (n = 60) groups. The procedures called for double ligation of three pairs and single ligation of two pairs of thoracic intercostal arteries in adult C57BL/6 mice. A laser Doppler probe was used in vivo on the spinal cords and intercostal arteries to document the extent of arterial ligation and spinal cord hypoperfusion. The Basso Mouse Scale for Locomotion, histological studies, and electron microscopy demonstrated postligation locomotive and histopathological changes. Results: Ligation induced a significant and instantaneous drop in blood flow in the intercostal arteries (% change; mean = −63.81; 95% CI, −72.28 to −55.34) and the thoracic spinal cord (% change; mean = −68.55; 95% CI, −80.23 to −56.87). Paralysis onset was immediate and of varying degree, with behavioral deficit stratified into three groups: 9.4% exhibited severe paralysis, 37.5% moderate paralysis, and 53.1% mild paralysis at day 1 (n = 32; P < 0.001). Mild and moderate paralysis was transient, gradually improving over time. Severe paralysis showed no improvement and exhibited a higher mortality rate (83%; n = 15 of 18) compared to moderately (33%; n = 6 of 18) and mildly (24%; n = 6 of 25) paralyzed mice (P < 0.001). The overall ligation group survival rate (84%; n = 46 of 55) was significantly lower than the sham group (100%; n = 48 of 48) with P = 0.003. Conclusions: The mouse model generates reproducible spinal cord hypoperfusion and accompanying histopathological ischemic spinal cord damage. The resulting anatomical changes and variable behavioral deficits mimic the variability in radiological and clinical findings in human patients. Editor’s Perspective: What We Already Know about This Topic: What This Article Tells Us That Is New: